Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IVA Rectal Cancer AJCC v7”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Early research (Phase 1)Study completedNCT03297710
What this trial is testing

TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery

Who this might be right for
Rectal AdenocarcinomaRecurrent Rectal CarcinomaStage IV Rectal Cancer AJCC v7+2 more
Mayo Clinic 7
Early research (Phase 1)Ended earlyNCT02757391
What this trial is testing

CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors

Who this might be right for
Colorectal AdenocarcinomaMetastatic CholangiocarcinomaMetastatic Colorectal Carcinoma+10 more
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT01417494
What this trial is testing

1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 102
Testing effectiveness (Phase 2)Ended earlyNCT02738606
What this trial is testing

Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Neoplasm in the Lung+5 more
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT03365882
What this trial is testing

S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

Who this might be right for
Colon AdenocarcinomaERBB2 Gene AmplificationRectal Adenocarcinoma+16 more
SWOG Cancer Research Network 240
Not applicableActive Not RecruitingNCT05038254
What this trial is testing

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

Who this might be right for
Clinical Stage IV Esophageal Adenocarcinoma AJCC v8Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+42 more
M.D. Anderson Cancer Center 750
Early research (Phase 1)Active Not RecruitingNCT02381561
What this trial is testing

Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy

Who this might be right for
Advanced Bile Duct CarcinomaStage II Esophageal Cancer AJCC v7Stage II Pancreatic Cancer AJCC v6 and v7+38 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)WithdrawnNCT02575508
What this trial is testing

Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer

Who this might be right for
Colon AdenocarcinomaMetastatic Pancreatic AdenocarcinomaPancreatic Adenocarcinoma+14 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT01802320
What this trial is testing

Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery

Who this might be right for
Colon Mucinous AdenocarcinomaColon Signet Ring Cell AdenocarcinomaRectal Mucinous Adenocarcinoma+13 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT01254617
What this trial is testing

Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer

Who this might be right for
Recurrent Colon CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+39 more
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT01217450
What this trial is testing

Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IVA Colon Cancer+4 more
National Cancer Institute (NCI) 33
Testing effectiveness (Phase 2)UnknownNCT03992456
What this trial is testing

Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Adenocarcinoma+27 more
Academic and Community Cancer Research United 12
Testing effectiveness (Phase 2)WithdrawnNCT02235324
What this trial is testing

Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+7 more
University of Southern California
Early research (Phase 1)Study completedNCT01383343
What this trial is testing

Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CarcinomaRecurrent Rectal CarcinomaStage IVA Colon Cancer+3 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT03396926
What this trial is testing

Pembrolizumab, Capecitabine, and Bevacizumab for Treating Colorectal Cancer

Who this might be right for
Microsatellite StableMismatch Repair Protein ProficientStage III Colorectal Cancer AJCC v7+5 more
University of California, San Francisco 44
Testing effectiveness (Phase 2)Study completedNCT03403634
What this trial is testing

Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver

Who this might be right for
Metastatic Carcinoma in the LiverRecurrent Colorectal CarcinomaStage IV Colorectal Cancer AJCC v7+2 more
Roswell Park Cancer Institute 19
Not applicableWithdrawnNCT01941173
What this trial is testing

Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IVA Colon Cancer+3 more
City of Hope Medical Center
Not applicableStudy completedNCT01807117
What this trial is testing

PET-MRI in Diagnosing Patients With Colon or Rectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IIA Colon Cancer+15 more
Case Comprehensive Cancer Center 15
Not applicableLooking for participantsNCT02107105
What this trial is testing

Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer

Who this might be right for
Rectal AdenocarcinomaStage I Rectal Cancer AJCC v8Stage II Rectal Cancer AJCC v8+11 more
M.D. Anderson Cancer Center 430
Not applicableEnded earlyNCT03765736
What this trial is testing

Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Rectal AdenocarcinomaStage III Colon Cancer AJCC v8+17 more
Academic and Community Cancer Research United 199
Next Page